Skip to main content
NCBI home page
Canadian Journal of Veterinary Research logoLink to Canadian Journal of Veterinary Research
. 2001 Jan;65(1):64–67.

Pharmacokinetics of enrofloxacin after intravenous and intramuscular administration in Angora goats.

M Elmas 1, B Tras 1, S Kaya 1, A L Bas 1, E Yazar 1, E Yarsan 1
PMCID: PMC1189645  PMID: 11227198

Abstract

Pharmacokinetics and bioavailability of enrofloxacin were determined after single intravenous (IV) and intramuscular (IM) administrations of 5 mg/kg body weight (BW) to 5 healthy adult Angora goats. Plasma enrofloxacin concentrations were measured by high performance liquid chromatography. Pharmacokinetics were best described by a 2-compartment open model. The elimination half-life and volume of distribution after IV and IM administrations were similar (t1/2beta, 4.0 to 4.7 h and Vd(ss),1.2 to 1.5 L/kg, respectively). Enrofloxacin was rapidly (t1/2a, 0.25 h) and almost completely absorbed (F, 90%) after IM administration. Mean plasma concentrations of enrofloxacin at 24 h after IV and IM administration (0.07 and 0.09 microg/mL, respectively) were higher than the minimal inhibitory concentration (MIC) values for most pathogens. In conclusion, once-daily IV and IM administration of enrofloxacin (5 mg/kg BW) in Angora goats may be useful in treatment of infectious diseases caused by sensitive pathogens.

Full text

PDF
64

Selected References

These references are in PubMed. This may not be the complete list of references from this article.

  1. Anadón A., Martínez-Larrañaga M. R., Díaz M. J., Bringas P., Martínez M. A., Fernàndez-Cruz M. L., Fernández M. C., Fernández R. Pharmacokinetics and residues of enrofloxacin in chickens. Am J Vet Res. 1995 Apr;56(4):501–506. [PubMed] [Google Scholar]
  2. Broome R. L., Brooks D. L., Babish J. G., Copeland D. D., Conzelman G. M. Pharmacokinetic properties of enrofloxacin in rabbits. Am J Vet Res. 1991 Nov;52(11):1835–1841. [PubMed] [Google Scholar]
  3. Cabanes A., Arboix M., Garcia Anton J. M., Reig F. Pharmacokinetics of enrofloxacin after intravenous and intramuscular injection in rabbits. Am J Vet Res. 1992 Nov;53(11):2090–2093. [PubMed] [Google Scholar]
  4. Cabanes A., Reig F., Antón J. M., Arboix M. Sustained release of liposome-encapsulated enrofloxacin after intramuscular administration in rabbits. Am J Vet Res. 1995 Nov;56(11):1498–1501. [PubMed] [Google Scholar]
  5. Fraile L. J., Martinez C., Aramayona J. J., Abadía A. R., Bregante M. A., García M. A. Limited capacity of neonatal rabbits to eliminate enrofloxacin and ciprofloxacin. Vet Q. 1997 Nov;19(4):162–167. doi: 10.1080/01652176.1997.9694764. [DOI] [PubMed] [Google Scholar]
  6. Kaartinen L., Panu S., Pyörälä S. Pharmacokinetics of enrofloxacin in horses after single intravenous and intramuscular administration. Equine Vet J. 1997 Sep;29(5):378–381. doi: 10.1111/j.2042-3306.1997.tb03143.x. [DOI] [PubMed] [Google Scholar]
  7. Kaartinen L., Pyörälä S., Moilanen M., Räisänen S. Pharmacokinetics of enrofloxacin in newborn and one-week-old calves. J Vet Pharmacol Ther. 1997 Dec;20(6):479–482. doi: 10.1046/j.1365-2885.1997.00100.x. [DOI] [PubMed] [Google Scholar]
  8. Kaartinen L., Salonen M., Alli L., Pyörälä S. Pharmacokinetics of enrofloxacin after single intravenous, intramuscular and subcutaneous injections in lactating cows. J Vet Pharmacol Ther. 1995 Oct;18(5):357–362. doi: 10.1111/j.1365-2885.1995.tb00604.x. [DOI] [PubMed] [Google Scholar]
  9. Küng K., Riond J. L., Wanner M. Pharmacokinetics of enrofloxacin and its metabolite ciprofloxacin after intravenous and oral administration of enrofloxacin in dogs. J Vet Pharmacol Ther. 1993 Dec;16(4):462–468. doi: 10.1111/j.1365-2885.1993.tb00212.x. [DOI] [PubMed] [Google Scholar]
  10. Mengozzi G., Intorre L., Bertini S., Soldani G. Pharmacokinetics of enrofloxacin and its metabolite ciprofloxacin after intravenous and intramuscular administrations in sheep. Am J Vet Res. 1996 Jul;57(7):1040–1043. [PubMed] [Google Scholar]
  11. Shumaker R. C. PKCALC: a BASIC interactive computer program for statistical and pharmacokinetic analysis of data. Drug Metab Rev. 1986;17(3-4):331–348. doi: 10.3109/03602538608998295. [DOI] [PubMed] [Google Scholar]
  12. Vancutsem P. M., Babish J. G., Schwark W. S. The fluoroquinolone antimicrobials: structure, antimicrobial activity, pharmacokinetics, clinical use in domestic animals and toxicity. Cornell Vet. 1990 Apr;80(2):173–186. [PubMed] [Google Scholar]
  13. Walker R. D., Stein G. E., Hauptman J. G., MacDonald K. H. Pharmacokinetic evaluation of enrofloxacin administered orally to healthy dogs. Am J Vet Res. 1992 Dec;53(12):2315–2319. [PubMed] [Google Scholar]

Articles from Canadian Journal of Veterinary Research are provided here courtesy of Canadian Veterinary Medical Association

RESOURCES